Factors Associated With Drug Consumption Without Scientific Evidence in Patients With Mild COVID-19 in Peru. Issue 8 (21st December 2022)

• Record Type: Journal Article
• Authors: Soriano-Moreno, David R.; Fernandez-Guzman, Daniel; Sangster-Carrasco, Lucero; Quispe-Vicuña, Carlos; Grados-Espinoza, Pamela; Ccami-Bernal, Fabricio; Morocho-Alburqueque, Noelia; Coba-Villan, Naomi; Velasquez-Fernandez, Randy; Nieto-Gutierrez, Wendy
• Is Part Of: Journal of patient safety. Volume 18:Issue 8(2022)
• Page Start: e1189
• Page End: e1195
• Publication Date: 2022-12-21
• Subjects: COVID-19 -- SARS-CoV-2 -- drug therapy -- antibiotic -- ivermectin -- associated factors (source: MESH); Patients -- Safety measures -- Periodicals; Medicine -- Practice -- Safety measures -- Periodicals; Medical errors -- Prevention -- Periodicals; 610.289
• DOI: 10.1097/PTS.0000000000001053
• Languages: English
• ISSNs: 1549-8417

Abstract

Abstract : Objective: This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods: An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results: Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41–0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36–0.65). Conclusions: Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.